Last April 2015, one of the researchers in the most successful country China has published a protein and paper that gives a details with its features and their usage of CRISPR gene editing in an early human embryos. It is an important discussion over the bioethics of such work has been raging.
The Hinxton Group has stood in favor of their research that includes using the CRISPR for editing genes in human stem cells. This innovation has its scale value on it especially to the basic research and the potential for the somatic clinical purposes. Genome editing has been colossal values for everyone as a great tool to address questions of human & animal biology as well as their similarities and differences.
The discussion encompassing of the uses of technologies for editing the genomes of human embryos is surely to continue.